Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
F3 encodes coagulation factor III which is a cell surface glycoprotein. Additionally we are shipping Coagulation Factor III (thromboplastin, Tissue Factor) Kits (93) and Coagulation Factor III (thromboplastin, Tissue Factor) Proteins (33) and many more products for this protein.
Showing 10 out of 189 products:
Human Monoclonal F3 Primary Antibody for EIA, FACS - ABIN112492
Morrissey, Fair, Edgington: Monoclonal antibody analysis of purified and cell-associated tissue factor. in Thrombosis research 1988
Show all 5 references for ABIN112492
Human Monoclonal F3 Primary Antibody for WB - ABIN396435
Bouchard, Mann, Butenas: No evidence for tissue factor on platelets. in Blood 2010
Show all 5 references for ABIN396435
Human Monoclonal F3 Primary Antibody for FACS - ABIN2662446
Whittle, Yoder, Carson: Human placental tissue factor: protease susceptibility of extracellular and cytoplasmic domains. in Thrombosis research 1996
Show all 3 references for ABIN2662446
Human Polyclonal F3 Primary Antibody for ELISA, WB - ABIN1450569
Scarpati, Wen, Broze, Miletich, Flandermeyer, Siegel, Sadler: Human tissue factor: cDNA sequence and chromosome localization of the gene. in Biochemistry 1987
Show all 2 references for ABIN1450569
Human Monoclonal F3 Primary Antibody for FACS - ABIN320295
Rancourt, Veress, Guo, Jones, Hendry-Hofer, White: Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide. in American journal of physiology. Lung cellular and molecular physiology 2011
Show all 2 references for ABIN320295
Human Polyclonal F3 Primary Antibody for IHC, ELISA - ABIN1531560
Gregory, Barlow, McLay, Kaul, Swarbreck, Dunham, Scott, Howe, Woodfine, Spencer, Jones, Gillson, Searle, Zhou, Kokocinski, McDonald, Evans, Phillips, Atkinson, Cooper, Jones, Hall, Andrews, Lloyd et al.: The DNA sequence and biological annotation of human chromosome 1. ... in Nature 2006
Show all 2 references for ABIN1531560
Human Polyclonal F3 Primary Antibody for IF (p), IHC (p) - ABIN708086
Gleeson, Martin, Ali, Kumar, Pillai, Kumar, OSullivan, Whelan, Stocca, Khider, Barry, OBrien, Caplice: Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy. in Stem cells (Dayton, Ohio) 2015
Human Polyclonal F3 Primary Antibody for IF (p) - ABIN708093
Liu, Wei, Zhang, Xu, Wang, Zhou: Procoagulant activity and cellular origin of microparticles in human amniotic fluid. in Thrombosis research 2014
Thrombin (show F2 Antibodies)-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.
These findings reveal a novel biological function and mechanism of the protein C (show PROC Antibodies) pathway in which protein S and the aPC (show APC Antibodies)-cleaved form of fV are cofactors for anti-inflammatory cell signaling by aPC (show APC Antibodies) in the context of endotoxemia and infection
Lung epithelial tissue factor regulates alveolar procoagulant activity and permeability in acute lung injury.
PGE2 increases both TF expression and activity through the regulation of the EP1 (show PTGER1 Antibodies)/SIRT1 (show SIRT1 Antibodies) pathway.
Fas (show FAS Antibodies)-initiated, caspase-3 (show CASP3 Antibodies)-dependent hepatocyte apoptosis increases tissue factor procoagulant activity through a mechanism involving phosphatidylserine externalization.
Heme promotes tissue factor-dependent coagulation activation and induces tissue factor expression on leukocytes in vivo.
TF is essential for the development of pericyte coverage of tumor microvessels and aPL (show FASL Antibodies)-induced tumor cell expression of chemokine ligand 2 (show CXCL2 Antibodies), a mediator of pericyte recruitment
Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor signaling.
Klkb1 (show KLKB1 Antibodies)(-/-) mice have a novel mechanism for thrombosis protection in addition to reduced contact activation. This pathway arises when bradykinin delivery to vasculature is compromised and mediated by increased receptor Mas (show MAS1 Antibodies), prostacyclin, Sirt1 (show SIRT1 Antibodies), and KLF4 (show KLF4 Antibodies)
study provides a novel mechanism for the posttranscriptional regulation of TF expression, indicating that this is selectively regulated by PARP-14 (show PARP14 Antibodies).
Activation of P2Y2R (show P2RY2 Antibodies) increased TF promoter activity and mRNA expression in coronary artery endothelial cells.
This study suggests that ROCK/YAP (show YAP1 Antibodies)/Egr-1 (show EGR1 Antibodies) signaling regulates tissue factor expression after stimulation with lipopolysaccharide in endothelial cells.
Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation.
The Role of Tissue Factor in Atherothrombosis and Coronary Artery Disease: Insights into Platelet Tissue Factor.
Structure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa.
Tissue Factor Expressed by Neutrophils
Clinical Significance of Tissue Factor-Exposing Microparticles in Arterial and Venous Thrombosis.
Data suggest that allosteric regulation of FVIIa activity by tissue factor/thromboplastin binding appear to involve direct interaction with FVIIa active site, stabilizing segment 215-217, activating loop 3, and leading to enhanced FVIIa activity.
Data indicate that IGF-binding protein 3 (IGFBP3 (show IGFBP3 Antibodies)) and F3 gene expression levels in formalin fixed paraffin embedded (FFPE) prostate cancer tissue would provide an improved survival prediction for prostate cancer patients.
asTF expression was associated with grade and stage in ER-positive breast tumors only. Tissue factor isoform and estrogen signaling share downstream targets in BrCa; concomitant asTF and estrogen signaling is required for BrCa cell proliferation.
Arterial (18)F-fluorodeoxyglucose uptake reflects balloon catheter-induced thrombus formation and tissue factor expression via nuclear factor-kappaB in rabbit atherosclerotic lesions.
Polycations could present a new class of anticoagulants with such unique upstream downregulation of blood coagulation, selectively blocking tissue factor-dependent factor VII (show TH Antibodies) activation.
Upregulated TF expression and increased plasma TF level during reperfusion period, reduced plasma TFPI-1 (show TFPI Antibodies) level during reperfusion period.
lectin-like oxidized LDL receptor (show OLR1 Antibodies) Oxidized low-density lipoprotein receptor (show LDLR Antibodies) 1expression appears to be closely associated with tissue factor expression, apoptotic events and morphological vulnerability in atherosclerotic lesions
Tissue factor expression on porcine neonatal islet cell clusters is an important initiator of instant blood-mediated inflammatory reaction in islet xenotransplantation.
Prolonged clopidogrel treatment reduced coronary tissue factor (TF) expression and tended to reduce the blood TF level post-PCI (show SERPINA5 Antibodies), thus possibly modulating the risk of late thrombosis.
Procoagulant porcine tissue factor is induced in primary pig aortic endothelial cells only by fresh human plasma, and not by heat-inactivated plasma.
myocardial infarction induced proinflammatory gene and protein expression in peripheral blood mononuclear cells of tissue factor cyclo-oxygenase-2, monocyte chemoattractant protein-1 (show CCL2 Antibodies) and CRP (show CRP Antibodies)
This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.
, coagulation factor III
, tissue factor
, brain tissue factor
, coagulation factor 3